leadf
logo-loader
viewRemote Monitored Systems

Remote Monitored Systems expects substantial revenues from P2F's face masks

P2F is setting up a production line that will be able to produce up to 5mln standard or anti-viral face masks per month.

Remote Monitored Systems -

Remote Monitored Systems PLC (LON:RMS) said it expects substantial revenues to be generated by new acquisition Pharm 2 Farm from the sale of anti-viral face masks.

The acquisition is still conditional on shareholder approval but  Trevor Brown, chief executive, said: ”Since we announced the proposed acquisition, the market for Pharm 2 Farm products, in particular for face masks, has continued to grow exponentially.

P2F is setting up a production line that will be able to produce up to 5mln standard or anti-viral face masks per month.

“The successful development of a face mask with anti-viral properties will, we believe, generate substantial revenue for the enlarged group," said Brown.

“Proof of Concept for the efficacy of the anti-viral mask is imminent and mask production is anticipated to commence in the first quarter of 2021".

Elsewhere, RMS said its Cloudveil risk management arm is currently negotiating with a London-based law firm over a security programme and had also bid for a testing contract for one of the UK’s largest public sector financial services institutions.

Gyrometric, meanwhile, is set to start a three-month trial at a Tarmac cement manufacturing operation now that a site has become available.

RMS added that for the half-year to June it recorded a loss of £253,000 (£381,000) on revenues of £58,000 (£18,000).

Current cash reserves are £360,000 said RMS.

Quick facts: Remote Monitored Systems

Price: 0.875 GBX

LSE:RMS
Market: LSE
Market Cap: £6.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Remote Monitored Systems named herein, including the promotion by the Company of Remote Monitored Systems in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

2 days, 18 hours ago

2 min read